Beijing Leadman Biochemistry Co (SZSE:300289) Accounts Payable & Accrued Expense : ¥63.6 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co Accounts Payable & Accrued Expense?

Beijing Leadman Biochemistry Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥64.9 Mil) to Dec. 2023 (¥90.4 Mil) but then declined from Dec. 2023 (¥90.4 Mil) to Mar. 2024 (¥63.6 Mil).

Beijing Leadman Biochemistry Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥98.7 Mil) to Dec. 2022 (¥93.4 Mil) and declined from Dec. 2022 (¥93.4 Mil) to Dec. 2023 (¥90.4 Mil).

Beijing Leadman Biochemistry Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Beijing Leadman Biochemistry Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Leadman Biochemistry Co Accounts Payable & Accrued Expense Chart

Beijing Leadman Biochemistry Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

104.26

89.68

98.75

93.39

90.39

Beijing Leadman Biochemistry Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															73.20	61.14	64.88	90.39	63.62

Beijing Leadman Biochemistry Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Beijing Leadman Biochemistry Co (SZSE:300289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.5 Hongda South Road, Beijing, CHN

Website

http://www.leadmanbio.com

Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.

Executives

Ding Yao Liang	Executives
Wang Xiao Hong	Supervisors
Zhang Hai Tao	Executives
Zhang Ya Li	Supervisors
Sun Qian	Director
Wang Jian Hua	Directors, executives
Wang Yi Xing	Directors, executives
Yang Lu Ping	Securities Affairs Representative
Niu Ju Hui	Secretary Dong
Zhang Kun	Director
Shen Guang Qian	Directors, executives
Ma Yan Wen	Director
Wang Lan Zhen	Directors, executives

Beijing Leadman Biochemistry Co (SZSE:300289) Headlines

No Headlines